Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
30 participants
INTERVENTIONAL
2022-06-28
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A RCT Comparing Dronabinol to a Placebo for Post-operative Pain in Total Joint Arthroplasty
NCT04298528
Investigating the Effect of Dronabinol on Post-surgical Pain
NCT04099355
Dronabinol in Total Knee Arthroplasty (TKA)
NCT04734080
Dexamethasone and Pain Following Total Knee Arthroplasty
NCT02271698
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
NCT03858231
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dronabinol
Patients will received dronabinol (5mg) twice a day for 7 days in addition to standard pain medication protocol after arthroscopic knee surgery
Dronabinol
5mg 2x daily for 7 days
Placebo
Patients will received placebo twice a day for 7 days in addition to standard pain medication protocol after arthroscopic knee surgery
Placebo
1 caplet 2x daily for 7 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dronabinol
5mg 2x daily for 7 days
Placebo
1 caplet 2x daily for 7 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who will undergo arthroscopic surgery of the knee including, but not limited to,
* Meniscectomy
* Synovectomy
* Chondroplasty
* Loose body removal
Exclusion Criteria
* Patients who cannot provide consent
* Patients who are pregnant, breast feeding, or are trying to become pregnant during the study period
* Patients with an allergy to any of the study drugs
* Patient who are lactose-intolerant
* Revision surgery
* Open surgery
* Comorbidities preventing surgery
* Patients with a history of mania, depression, or schizophrenia
* Patients taking any of the following drugs or supplements
* Anticholinergic agents
* Benzodiazepines
* Central nervous system depressants
* Droperidol
* Hydroxyzine
* Levomepromazine or methotrimeprazine
* Monoamine oxidase inhibitors
* Ritonavir
* Selective serotonin reuptake inhibitors
* Sympathomimetics
* St. John's Wort
* Current diagnosed alcohol or drug abuse
* Patients who cannot or will not abide by the medication restrictions listed below
Medication restrictions
* Participants must agree to abstain from using recreational or medical marijuana products or cannabidiol (CBD) in any form during the treatment period
* Participants should not drink alcohol or take other drugs while taking the study drug or hydrocodone/acetaminophen
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vehniah Tjong
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vehniah K Tjong, MD
Role: PRINCIPAL_INVESTIGATOR
Northwestern Feinberg School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00213383
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.